$5.95 -0.09 (%) Biocryst Pharmaceuticals Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Unusual Options Activity: TSO, AMD, DAL & More

    TalkMarkets | Dec. 30, 2016 | 09:28AM EST
  2. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets | Dec. 19, 2016 | 20:51PM EST
  3. Benzinga's Top Downgrades

    Benzinga | Feb. 9, 2016 | 09:15AM EST
  4. Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals Shares Drop Following Announcement of Failed Avoralstat Trial Results

    Benzinga | Feb. 8, 2016 | 14:32PM EST
  5. Mid-Day Market Update: Dow Tumbles Over 350 Points; Apollo Education Shares Spike Higher

    Benzinga | Feb. 8, 2016 | 12:05PM EST
  6. Mid-Morning Market Update: Markets Open Lower; Hasbro Beats Q4 Estimates

    Benzinga | Feb. 8, 2016 | 09:53AM EST
  7. BioCryst Pharmaceuticals Is Plummeting 65%

    Benzinga | Feb. 8, 2016 | 08:18AM EST
  8. Biocryst Pharmaceuticals Says Oral Administration Of Avoralstat In Opus-2 Was Generally Safe And Well Tolerated

    Benzinga | Feb. 8, 2016 | 06:03AM EST
  9. 10 Stocks Moving In Tuesday's Pre-Market Session

    Benzinga | Jan. 26, 2016 | 08:26AM EST
  10. Benzinga's Top Downgrades

    Benzinga | Nov. 11, 2015 | 09:45AM EST
  11. Morning Market Losers

    Benzinga | Oct. 8, 2015 | 08:55AM EST
  12. US Stock Futures Down Ahead Of Fed Minutes

    Benzinga | Oct. 8, 2015 | 05:50AM EST
  13. BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

    Benzinga | Oct. 8, 2015 | 04:59AM EST
  14. Robert Ingram Named to BioCryst's Board of Directors

    Benzinga | Aug. 6, 2015 | 06:36AM EST
  15. 6 Movers To Keep An Eye On Next Week

    Benzinga | Jul. 18, 2015 | 09:18AM EST
  16. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX4430 NDA Enabling CMC and Non-Clinical Toxicology Studies

    Benzinga | Jul. 2, 2015 | 12:34PM EST
  17. Benzinga's Top Upgrades

    Benzinga | Jun. 30, 2015 | 08:50AM EST
  18. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga | Jun. 23, 2015 | 06:04AM EST
  19. Tekmira falls on Ebola news

    IBD | Jun. 19, 2015 | 17:50PM EST
  20. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD | Jun. 19, 2015 | 11:49AM EST
  21. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga | Jun. 19, 2015 | 09:04AM EST
  22. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | May. 13, 2015 | 06:49AM EST
  23. BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema

    Benzinga | May. 13, 2015 | 05:58AM EST
  24. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 08:36AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Apr. 20, 2015 | 09:09AM EST
  26. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected Q4 Loss

    Benzinga | Feb. 18, 2015 | 08:54AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 14, 2015 | 08:06AM EST
  28. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  29. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  30. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Dec. 23, 2014 | 07:08AM EST
  31. BioCryst Pharmaceuticals'

    IBD | Dec. 22, 2014 | 18:28PM EST
  32. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga | Dec. 22, 2014 | 09:06AM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 22, 2014 | 08:09AM EST
  34. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Dec. 18, 2014 | 07:35AM EST
  35. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  36. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey

    Benzinga | Dec. 4, 2014 | 10:27AM EST
  37. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 09:44AM EST
  38. Making Money With Charles Payne: 10/24/14

    FoxBusiness | Oct. 24, 2014 | 17:00PM EST
  39. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 13:52PM EST
  40. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 09:58AM EST
  41. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 17:00PM EST
  42. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 17:00PM EST
  43. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 12:04PM EST
  44. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga | Oct. 8, 2014 | 06:19AM EST
  45. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 17:00PM EST
  46. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 7, 2014 | 07:10AM EST
  47. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 Trial Results

    Benzinga | Oct. 7, 2014 | 06:10AM EST
  48. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 17:00PM EST
  49. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD | Oct. 6, 2014 | 13:31PM EST
  50. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 13:08PM EST
Trading Center